Migraine pathophysiology and its clinical implications

Cephalalgia, Supplement

Volumn 24, Issue 2, 2004, Pages 2-7

  Silberstein, Stephen D ^a,b  

^a JEFFERSON HEADACHE CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Allodynia; Aura; Migraine; Sensitization; Triptan

Indexed keywords

ANTIMIGRAINE AGENT; ACETYLCHOLINE; BRADYKININ; CALCITONIN GENE RELATED PEPTIDE; CALCIUM; GLUTAMIC ACID; HISTAMINE; NEUROKININ A; NEUROPEPTIDE; NORADRENALIN; PROSTAGLANDIN E2; SEROTONIN 1D RECEPTOR; SEROTONIN 1F RECEPTOR; SUBSTANCE P; TRIPTAN DERIVATIVE;

ALLODYNIA; CONFERENCE PAPER; DRUG EFFICACY; HUMAN; MENINX; MIGRAINE; NERVE STIMULATION; NEUROGENIC INFLAMMATION; PATHOPHYSIOLOGY; SENSITIZATION; SENSORY NERVE; SENSORY NERVE CELL; SPREADING CORTICAL DEPRESSION; TRIGEMINAL NUCLEUS; VASODILATATION; ARTICLE; BOLD SIGNAL; BRAIN CORTEX; BRAIN STEM; DISEASE COURSE; MIGRAINE AURA; NERVE CELL; NERVE ENDING; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; NORADRENERGIC SYSTEM; PROTEIN SECRETION; SEROTONINERGIC SYSTEM; VISUAL CORTEX;

EID: 10344242416     PISSN: 08001952     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2004.00892.x     Document Type: Conference Paper

References (33)

1. Graham JR, Wolff HG. Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 1938; 39:737-63.
2. Lauritzen M. Cerebral blood flow in migraine and cortical spreading depression. Acta Neurol Scand Suppl 1987; 113:1-40.
3. Leão AA. Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944; 7:359-90.
4. Leão AA, Morison RS. Propagation of spreading cortical depression. J Neurophysiol 1945; 8:33-46.
5. James MF, Smith MI, Bockhorst KH, et al. Cortical spreading depression in the gyrencephalic feline brain studied by magnetic resonance imaging. J Physiol 1999; 519:415-25.
6. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain 1994; 117:199-210.
7. Lashley KS. Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol Psychiatry 1941; 46:331-9.
8. Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 2001; 98:4687-92.
9. Bowyer SM, Aurora KS, Moran JE, Tepley N, Welch KM. Magnetoencephalographic fields from patients with spontaneous and induced migraine aura. Ann Neurol 2001; 50:582-7.
10. Welch KM, D'Andrea G, Tepley N, Barkley G, Ramadan NM. The concept of migraine as a state of central neuronal hyperexcitability. Neurol Clin 1990; 8:817-28.
11. Tepper SJ, Rapoport A, Sheftell F. The pathophysiology of migraine. Neurology 2001; 7:279-86.
12. Fusco M, D'Andrea G, Micciche F, Stecca A, Bernardini D, Cananzi AL. Neurogenic inflammation in primary headaches. Neurol Sci 2003; 24 (Suppl. 2):S61-S64.
13. Pietrobon D, Striessnig J. Neurobiology of migraine. Nat Rev Neurosci 2003; 4:386-98.
14. Buzzi MG, Moskowitz MA. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 1990; 99:202-6.
15. Buzzi MG, Carter WB, Shimizu T, Heath H III, Moskowitz MA. Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology 1991; 30:1193-200.
16. Buzzi MG, Dimitriadou V, Theoharides TC, Moskowitz MA. 5-hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation. Brain Res 1992; 583:137-49.
17. Saito K, Markowitz S, Moskowitz MA. Ergot alkaloids block neurogenic extravasation in dura mater: proposed action in vascular headaches. Ann Neurol 1988; 24:732-7.
18. Iadecola C. From CSD to headache: a long and winding road. Nat Med 2002; 8:110-2.
19. Somjen GG. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev 2001; 81:1065-96.
20. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002; 8:136-42.
21. Tracey I, Ploghaus A, Gati JS, et al. Imaging attentional modulation of pain in the periaqueductal gray in humans. J Neurosci 2002; 22:2748-52.
22. Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995; 1:658-60.
23. Strassman AM, Raymond SA, Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature 1996; 384:560-4.
24. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann Neurol 2000; 47:614-24.
25. Burstein R, Yamamura H, Malick A, Strassman AM. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 1998; 79:964-82.
26. Minami T, Okuda-Ashitaka E, Hori Y, et al. Involvement of primary afferent C-fibres in touch-evoked pain (allodynia) induced by prostaglandin E2. Eur J Neurosci 1999; 11:1849-56.
27. Malick A, Strassman RM, Burstein R. Trigeminohypothalamic and reticulohypothalamic tract neurons in the upper cervical spinal cord and caudal medulla of the rat. J Neurophysiol 2000; 84:2078-112.
28. Steen KH, Steen AE, Reeh PW. A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro. J Neurosci 1995; 15:3982-9.
29. 1B/1D receptor agonist zolmitriptan blocks central sensitization in the trigeminal nucleus caudalis. AAN Abstracts 2004; S63:001.
30. Luo J, Piovesan E, Oshinsky ML. Sensitization induced neurochemistry changes in the trigeminal nucleus caudalis. Society for Neuroscience, 2003: Prog no. 175.10 2003 Abstract Viewer.
31. Ramadan NM. The link between glutamate and migraine. CNS Spectr 2003; 8:446-9.
32. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack. Brain 2000; 123:1703-9.
33. Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 2004; 55:19-26.